Recent Quotes
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

62.56 +0.47 (+0.76%)
Official Closing Price Updated: 4:10 PM EDT, Jul 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,070,355
Open 62.40
Bid (Size) 62.20 (600)
Ask (Size) 63.00 (500)
Prev. Close 62.09
Today's Range 62.22 - 63.44
52wk Range 42.52 - 62.89
Shares Outstanding 2,222,113,553
Dividend Yield 4.03%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now ↗
As investors rotate toward value, Altria, Bristol Myers Squibb, and American Electric Power stand out as reliable dividend stocks with strong payout growth histories and defensive appeal. 
Via MarketBeat
Topics Economy
News headline image
Israel "Izzy" Englander Increased His Position in This Pharma Stock by 780%. Does He Know Something Wall Street Doesn't? ↗
Analysts aren't nearly as bullish about Bristol Myers Squibb as this billionaire hedge fund manager is. 
Via The Motley Fool
Topics Intellectual Property

Performance

YTD
+17.0%
+17.0%
1 Month
+8.8%
+8.8%
3 Month
+8.3%
+8.3%
6 Month
+14.6%
+14.6%
1 Year
+31.7%
+31.7%

More News

Read More
News headline image
Is Bristol Myers Squibb's Dividend Too Good to Be True? Here's My Honest Answer ↗
Via The Motley Fool
Topics Intellectual Property
Bristol Myers Squibb Co (NYSE:BMY): A High Yield Dividend Stock Backed by Strong Profitability ↗
Via Chartmill
Bristol-Myers Squibb Co (NYSE:BMY): A High-Yield Dividend Play with Cautionary Notes ↗
Via Chartmill
News headline image
3 Healthcare Stocks We Keep Off Our Radar
Via StockStory
News headline image
BioNTech's Next Act Has Nothing to Do With COVID. Here's the $500 Billion Market Some Investors Are Ignoring ↗
Via The Motley Fool
News headline image
Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA
From Bristol Myers Squibb
Via Business Wire
News headline image
Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb ↗
Via The Motley Fool
Topics Government Intellectual Property
News headline image
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
From Bristol Myers Squibb
Via Business Wire
News headline image
2 Dirt Cheap Dividend Stocks to Buy With $1,000 Right Now ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
3 High-Yield Dividend Stocks to Buy and Hold Forever (Hint: AbbVie Makes the List) ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Is Bristol Myers Squibb's 4.3% Dividend Yield Safe? Here's What Investors Need to Know. ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Vanguard Is Bullish on Value Stocks and Fixed Income. Are These 2 ETFs a Good Buy? ↗
Via The Motley Fool
Topics Artificial Intelligence Bonds ETFs
News headline image
2 Cash-Producing Stocks Worth Investigating and 1 Facing Headwinds
Via StockStory
News headline image
Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
News headline image
Rolling Into Spreads: Extend Profit Potential with Lower Risk ↗
Via InvestorPlace
News headline image
3 Unpopular Stocks with Questionable Fundamentals
Via StockStory
News headline image
Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis
Via Investor Brand Network
News headline image
3 Reasons to Buy Bristol Myers Squibb Stock ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
1 S&P 500 Stock with Solid Fundamentals and 2 We Avoid
Via StockStory
Topics Stocks
News headline image
The Quest to Repair What Multiple Sclerosis Takes Away
From BioMedWire
Via GlobeNewswire
News headline image
Bristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026
From Bristol Myers Squibb
Via Business Wire
News headline image
Bristol Myers Squibb Announces Dividend
From Bristol Myers Squibb
Via Business Wire

Frequently Asked Questions

Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 62.56
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 07/27/26 04:10 PM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 139.02B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 139B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>